Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Adversea is an innovative platform that leverages artificial intelligence to conduct background checks and risk assessments for organizations looking to evaluate potential risks associated with individuals or entities. Its primary feature revolves around adverse media screening, which meticulously tracks and reviews news articles to reveal any negative information that might pose reputational, legal, or financial dangers. Users simply input the name of a person or organization, prompting the system to automatically retrieve pertinent media coverage and utilize sophisticated AI technology to compile the results into a detailed summary that encompasses fundamental entity details, any current or historical legal challenges, instances of corruption, financial misconduct, violence, and various other risk factors. The platform enhances trustworthiness by providing direct links to the original sources, enabling users to corroborate the findings and uphold transparency during their due diligence efforts. Additionally, Adversea broadens its screening features by detecting related social media accounts, thus offering a more comprehensive view of an entity's online presence. This multifaceted approach equips organizations with the tools they need to make informed decisions while mitigating potential risks.
Description
Ripjar is a sophisticated platform that leverages artificial intelligence to provide risk and compliance intelligence for various entities, including businesses, financial organizations, government bodies, and security teams, enabling them to effectively identify, track, and analyze threats and risks associated with individuals, organizations, and data on a large scale. By utilizing cutting-edge machine learning, natural language processing, and advanced entity resolution techniques, Ripjar integrates and evaluates both structured and unstructured data from various sources such as sanctions and watchlists, adverse media, internal documents, transactions, and other third-party information, resulting in dynamic risk profiles that refresh in real time, thereby greatly minimizing both false positives and negatives in comparison to conventional screening methods. Among its offerings are solutions for AML name screening and monitoring, which merge diverse compliance results into a cohesive overview; adverse media screening that uncovers hidden and reputational risk indicators; and third-party risk management that consistently evaluates compliance, ethical, prudential, and supply chain risks, ensuring a comprehensive approach to risk assessment. Additionally, Ripjar's platform is designed to adapt to evolving threats, maintaining its effectiveness in a landscape of increasing complexity and regulatory demands.
API Access
Has API
Yes
API Access
Has API
No
Integrations
JSON
No
Pricing Details
€0.19 per request
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
No
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
No
Vendor Details
Company Name
Adversea
Country
Slovakia
Website
adversea.com
Vendor Details
Company Name
Ripjar
Founded
2013
Country
United Kingdom
Website
ripjar.com
Product Features
Background Check
Batch Processing
No
Employment Screening
No
Online Applications
No
Screening Services Integration
No
Self Service Portal
No
Status Tracking
No
Tenant Screening
No
Product Features
AML
Behavioral Analytics
No
Case Management
No
Compliance Reporting
No
Identity Verification
No
Investigation Management
No
PEP Screening
No
Risk Assessment
No
SARs
No
Transaction Monitoring
No
Watch List
No